Ventricular assist devices and total artificial hearts: A combined registry experience

摘要: Data submitted voluntarily to the combined registry for past 6 years on use of ventricular assist devices postcardiotomy cardiogenic shock in 965 patients and circulatory support conjunction with cardiac transplantation 544 were analyzed. Of those whose function was expected recover, approximately 45% weaned from 25% discharged hospital. Weaning status hospital discharge not different regardless type original operative procedure or pump design used. In potential transplant group, 69% ultimately underwent 66% The demographics (age sex) this group parallel undergoing isolated transplantation, 1- 2-year survival estimates requiring only univentricular equivalent having orthotopic transplantation. Ventricular are able provide reasonable safe both bridge-to-transplantation applications.